|
" Acetaminophen : "
Atash Javaherian and Pasha Latifpour, editors.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
726229
|
| Doc. No
|
:
|
b545961
|
| Main Entry
|
:
|
Atash Javaherian and Pasha Latifpour, editors.
|
| Title & Author
|
:
|
Acetaminophen : : properties, clinical uses and adverse effects\ Atash Javaherian and Pasha Latifpour, editors.
|
| Publication Statement
|
:
|
New York: Nova Science ; Lancaster : Gazelle [distributor], ©2012.
|
| Series Statement
|
:
|
Pharmacology-research, safety testing, and regulation series.; Public health in the 21st century series.
|
| Page. NO
|
:
|
(x, 206 pages) : illustrations
|
| ISBN
|
:
|
1619423758
|
|
|
:
|
: 9781619423756
|
| Contents
|
:
|
ACETAMINOPHEN "; "ACETAMINOPHEN "; "CONTENTS "; "PREFACE "; "ACETAMINOPHEN (PARACETAMOL): PROPERTIES, CLINICAL USES, AND ADVERSE EFFECTS"; "ABSTRACT "; "1. INTRODUCTION "; "2. PROPERTIES "; "2.1. Chemistry "; "2.2. Pharmacokinetics "; "2.2.1. Absorption "; "2.2.1.1. Immediate Release "; "2.2.1.2. Extended Release "; "2.2.1.3. Intravenous "; "2.2.2. Distribution "; "2.2.2.1. Spinal Fluid"; "2.2.2.2. Placental Barrier "; "2.2.2.3. Breast Milk "; "2.2.3. Metabolism "; "2.2.4. Elimination "; "2.2.5. Fetus, Neonates, Infants, and Children" "2.2.6. Geriatric ""3. CLINICAL USES "; "3.1. Antipyresis "; "3.2. Analgesia "; "4. SPECIAL POPULATIONS "; "4.1. Chronic Liver Disease "; "4.2. Renal Disease "; "4.3. Calorie Restricted Patients "; "4.4. HIV "; "4.5. Gilbert�s Syndrome "; "5. ADVERSE EVENTS "; "5.1. Allergy and Hypersensitivity "; "5.2. Central Nervous System "; "5.3. Gastrointestinal "; "5.4. Hemotologic and Hemostatic "; "5.5. Hepatic Toxicity "; "5.6. Pregnancy and Lactation "; "5.7. Renal "; "6. DDIS "; "6.1. Overdose "; "6.1.1. NAC Treatment " "7. ACETAMINOPHEN FORMULATIONS ""7.1. Combinations "; "7.2. IV Formulation "; "CONCLUSION "; "REFERENCES "; "CLINICAL AND EXPERIMENTAL RELEVANCE OF HYPOTHERMIA IN ACETAMINOPHEN HEPATOTOXICITY "; "ABSTRACT "; "1. INTRODUCTION "; "2. APAP-INDUCED HEPATOTOXICITY IN PATIENTS WITH ALF"; "3. APAP-INDUCED HEPATOTOXICITY IN EXPERIMENTAL MODELS"; "3.a. Determinants of APAP-Induced Hepatotoxicity in Experimental Animal Models "; "3.b. Histopathology "; "4. MECHANISMS OF APAP-INDUCED LIVER INJURY "; "5. BODY TEMPERATURE, APAP AND THE LIVER " "5.a. Reduction of Body Temperature Due to APAP in Humans ""5.b. Reduction of Body Temperature in Experimental Animal Models of Liver Injury"; "6. RELEVANCE OF BODY TEMPERATURE FOR APAP-INDUCED ALF "; "6.1. Effects of Hypothermia on the Development of Brain Edema and Intracranial Hypertension in ALF"; "6.2. Effects of Hypothermia on the Progression of Liver Injury"; "CONCLUSIONS "; "REFERENCES "; "NOVEL APPLICATIONS OF ACETAMINOPHEN "; "ABSTRACT "; "1. INTRODUCTION "; "2. CHRONIC ACETAMINOPHEN INGESTION CAN IMPROVE BLOOD GLUCOSE CONTROL " "3. long term acetaminophen ingestion can improve skeletal muscle structure and function""4. acetaminophen possesses cardioprotective and neuroprotective properties "; "5. acetaminophen exhibits potent antioxidant activity "; "conclusions and perspectives "; "conflict of interest statement "; "acknowledgments "; "references "; "advanced methods for the removal of acetaminophen from water "; "abstract "; "1. introduction "; "2. pharmaceuticals as emergent pollutants "; "3. acetaminophen in water resources "; "4. acetaminophen removal and degradation "
|
| Subject
|
:
|
Acetaminophen.
|
| Subject
|
:
|
MEDICAL -- Pain Medicine.
|
| LC Classification
|
:
|
RM666.A19A837 2012
|
| Added Entry
|
:
|
Atash Javaherian
|
|
|
:
|
Pasha Latifpour
|
| |